Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3398416 | Clinical Microbiology and Infection | 2009 | 5 Pages |
Abstract
Mucormycosis (zygomycosis) is an uncommon infection that afflicts severely immunocompromised patients and those with poorly controlled diabetes mellitus. A recent increase in the incidence of mucormycosis at many transplant centres has been linked to the introduction and widespread use of voriconazole prophylaxis in these high-risk populations. However, it is not known if this association reflects a true epidemiological link or represents a marker of changing immunosuppression occurring in parallel with the evolution of transplant practices and immunosuppression strategies.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
G.N. Pongas, R.E. Lewis, G. Samonis, D.P. Kontoyiannis,